Aspyrian Therapeutics Obtains $15,199,998 New Funding Round

  • Feed Type
  • Date
  • Company Name
    Aspyrian Therapeutics
  • Mailing Address
    10575 Roselle Street San Diego, CA 92121 USA
  • Company Description
    Developing the next generation of targeted therapies for oncology.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy